{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:35:34Z","timestamp":1793500534961,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jaci.2021.11.016","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T07:17:17Z","timestamp":1641367037000},"page":"24-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity"],"prefix":"10.1016","volume":"149","author":[{"given":"Aristine","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.11.016_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-immunol-032713-120222","article-title":"Anticytokine autoantibody-associated immunodeficiency","volume":"32","author":"Browne","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/QCO.0000000000000561","article-title":"Anticytokine autoantibodies leading to infection: early recognition, diagnosis and treatment options","volume":"32","author":"Barcenas-Morales","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00439-020-02180-0","article-title":"Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?","volume":"139","author":"Ku","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaci.2021.11.016_bib4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.016_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.11.016_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates\u00a0with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.11.016_bib7","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/cid\/ciu968","article-title":"Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated\/extrapulmonary nocardiosis","volume":"60","author":"Rosen","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib9","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.3389\/fimmu.2019.02629","article-title":"Anti-IL6 autoantibodies in an infant with CRP-less septic shock","volume":"10","author":"Bloomfield","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib10","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/annrheumdis-2012-202768","article-title":"Suppression of elevations in serum C reactive protein levels by anti-IL-6 autoantibodies in two patients with severe bacterial infections","volume":"72","author":"Nanki","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"6515","key":"10.1016\/j.jaci.2021.11.016_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.11.016_bib12","doi-asserted-by":"crossref","first-page":"e2705","DOI":"10.1093\/cid\/ciaa1274","article-title":"Primary and acquired immunodeficiencies associated with severe varicella-zoster virus infections","volume":"73","author":"Ansari","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2249.1991.tb05686.x","article-title":"Naturally occurring anti-interferon-alpha 2a antibodies in patients with acute viral hepatitis","volume":"85","author":"Ikeda","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/ki.1991.276","article-title":"Anti-interleukin-1 alpha autoantibodies in hemodialysis patients","volume":"40","author":"Sunder-Plassmann","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaci.2021.11.016_bib15","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/art.39607","article-title":"Distinct functions of autoantibodies against interferon in systemic lupus erythematosus: a comprehensive analysis of anticytokine autoantibodies in common rheumatic diseases","volume":"68","author":"Gupta","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2021.11.016_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/iid3.109","article-title":"IL-6-specific autoantibodies among APECED and thymoma patients","volume":"4","author":"K\u00e4rner","year":"2016","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib17","first-page":"136","article-title":"Anti-cytokine autoantibodies in autoimmune diseases","volume":"1","author":"Cappellano","year":"2012","journal-title":"Am J Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib18","first-page":"8","article-title":"Anti-interferon-gamma antibodies in sera from HIV infected patients","volume":"3","author":"Caruso","year":"1989","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.jaci.2021.11.016_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1442-200x.2001.01341.x","article-title":"Anti-interleukin-8 autoantibody in the tracheobronchial aspirate of infants with chronic lung disease","volume":"43","author":"Takasaki","year":"2001","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jaci.2021.11.016_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12967-015-0695-6","article-title":"Anti-cytokine autoantibodies in postherpetic neuralgia","volume":"13","author":"Bayat","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.jaci.2021.11.016_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-2478(91)90102-G","article-title":"Human anti-interleukin 1 alpha antibodies","volume":"30","author":"Hansen","year":"1991","journal-title":"Immunol Lett"},{"issue":"62","key":"10.1016\/j.jaci.2021.11.016_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1479-5876-8-97","article-title":"Rapid induction of autoantibodies during ARDS and septic shock","volume":"8","author":"Burbelo","year":"2010","journal-title":"J Transl Med"},{"key":"10.1016\/j.jaci.2021.11.016_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0171-2985(89)80049-X","article-title":"Interferon-gamma: a review","volume":"179","author":"Ijzermans","year":"1989","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaci.2021.11.016_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.coi.2021.05.007","article-title":"Anti-interferon-\u03b3 autoantibody-associated immunodeficiency","volume":"72","author":"Shih","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb1662","article-title":"Human inborn errors of immunity: an expanding universe","volume":"5","author":"Notarangelo","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2003-04-1065","article-title":"Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans","volume":"103","author":"H\u00f6flich","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.11.016_bib28","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity","volume":"38","author":"D\u00f6ffinger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/1535370220981579","article-title":"Minireview: insights into anti-interferon-\u03b3 autoantibodies","volume":"246","author":"Chawansuntati","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jaci.2021.11.016_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128481","article-title":"HLA-DRB1 and HLA-DQB1 are associated with adult-onset immunodeficiency with acquired anti-interferon-gamma autoantibodies","volume":"10","author":"Pithukpakorn","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2021.11.016_bib31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaci.2015.09.018","article-title":"Anti-IFN-\u03b3 autoantibodies are strongly associated with HLA-DR\u221715:02\/16:02 and HLA-DQ\u221705:01\/05:02 across Southeast Asia","volume":"137","author":"Ku","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib32","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s10875-014-0073-9","article-title":"The first US domestic report of disseminated Mycobacterium avium complex and anti-interferon-\u03b3 autoantibodies","volume":"34","author":"O'Connell","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib33","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s10875-019-00652-1","article-title":"Juvenile-onset immunodeficiency secondary to anti-interferon-gamma autoantibodies","volume":"39","author":"Liew","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s15010-017-1060-x","article-title":"A 38-year-old woman with necrotising cervical lymphadenitis due to Histoplasma capsulatum","volume":"45","author":"van de Vosse","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.jaci.2021.11.016_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12879-020-04984-x","article-title":"Disseminated Mycobacterium simiae infection in a patient with adult-onset immunodeficiency due to anti-interferon-gamma antibodies - a case report","volume":"20","author":"Keragala","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib36","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1097\/QAD.0000000000001644","article-title":"Neutralizing antiinterferon-\u03b3 autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy","volume":"31","author":"Wu","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2021.11.016_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cid\/ciz786","article-title":"Natural history and evolution of anti-interferon-\u03b3 autoantibody-associated immunodeficiency syndrome in Thailand and the United States","volume":"71","author":"Hong","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2340\/00015555-2959","article-title":"Skin manifestations in patients with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: a relationship with systemic infections","volume":"98","author":"Jutivorakool","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaci.2021.11.016_bib39","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/PAS.0000000000001731","article-title":"Lymphadenopathy associated with neutralizing anti-interferon-gamma autoantibodies could have monoclonal T-cell proliferation indistinguishable from malignant lymphoma and treatable by antibiotics: a clinicopathologic study","volume":"45","author":"Yuan","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2021.11.016_bib40","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/PAS.0000000000001736","article-title":"Morphologic spectrum of lymphadenopathy in adult-onset immunodeficiency (anti-interferon-\u03b3 autoantibodies)","volume":"45","author":"Thingujam","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2021.11.016_bib41","doi-asserted-by":"crossref","first-page":"1684.e1","DOI":"10.1016\/j.cmi.2020.02.030","article-title":"Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies","volume":"26","author":"Wu","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaci.2021.11.016_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003927","article-title":"Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-\u03b3 autoantibodies and disseminated nontuberculous mycobacterial infections","volume":"95","author":"Chi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2021.11.016_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/1535370218764086","article-title":"Characterization of anti-interferon-\u03b3 antibodies in HIV-negative immunodeficient patients infected with unusual intracellular microorganisms","volume":"243","author":"Wipasa","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jaci.2021.11.016_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7883\/yoken.JJID.2015.340","article-title":"Cryptococcosis in anti-interferon-gamma autoantibody-positive patients: a different clinical manifestation from HIV-infected patients","volume":"70","author":"Chetchotisakd","year":"2017","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib45","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017609","article-title":"Bacillus cereus isolated from a positive bone tissue culture in a patient with osteolysis and high-titer anti-interferon-\u03b3 autoantibodies: a case report","volume":"98","author":"Qiu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2021.11.016_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jiac.2013.08.003","article-title":"Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients","volume":"20","author":"Shima","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jaci.2021.11.016_bib47","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3389\/fimmu.2019.01517","article-title":"Functional analysis of anti-cytokine autoantibodies using flow cytometry","volume":"10","author":"Merkel","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib48","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/cid\/cix372","article-title":"Repurposing QuantiFERON for detection of neutralizing interferon-\u03b3 autoantibodies in patients with nontuberculous mycobacterial infections","volume":"65","author":"Su\u00e1rez","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmi.2017.06.029","article-title":"Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-\u03b3 autoantibodies in patients with disseminated nontuberculous mycobacterial infection","volume":"24","author":"Wu","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaci.2021.11.016_bib50","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","article-title":"Anti-CD20 (rituximab) therapy for anti-IFN-\u03b3 autoantibody-associated nontuberculous mycobacterial infection","volume":"119","author":"Browne","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.11.016_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6473629","article-title":"Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated","volume":"2018","author":"Chetchotisakd","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2021.11.016_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa035","article-title":"Prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-\u03b3 autoantibodies","volume":"7","author":"Laisuan","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib53","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10875-017-0425-3","article-title":"Rituximab restores IFN-\u03b3-STAT1 function and ameliorates disseminated Mycobacterium avium infection in a patient with anti-interferon-\u03b3 autoantibody","volume":"37","author":"Koizumi","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib54","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/cid\/cit809","article-title":"Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-\u03b3 autoantibody","volume":"58","author":"Czaja","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib55","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/cid\/ciaa1086","article-title":"Daratumumab (anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-interferon-\u03b3 autoantibodies","volume":"72","author":"Ochoa","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2021.11.016_bib56","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/cid\/ciaa1098","article-title":"Anti-interferon gamma autoantibody and disseminated nontuberculous mycobacteria infection: what should be done to improve its clinical outcome?","volume":"72","author":"Koizumi","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"30","key":"10.1016\/j.jaci.2021.11.016_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau6759","article-title":"Human IFN-\u03b3 immunity to mycobacteria is governed by both IL-12 and IL-23","volume":"3","author":"Mart\u00ednez-Barricarte","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib58","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm.3895","article-title":"IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases","volume":"21","author":"Teng","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2021.11.016_bib59","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0140-6736(05)64012-3","article-title":"Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease","volume":"350","author":"Meager","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.11.016_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib61","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1182\/blood-2010-05-286161","article-title":"Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia","volume":"116","author":"Burbelo","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.11.016_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10875-016-0364-4","article-title":"Disseminated cryptococcosis due to anti-granulocyte-macrophage colony-stimulating factor autoantibodies in the absence of pulmonary alveolar proteinosis","volume":"37","author":"Kuo","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib63","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/myc.13247","article-title":"Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: an underappreciated association","volume":"64","author":"Viola","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.jaci.2021.11.016_bib64","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0014-5793(98)01668-8","article-title":"Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor","volume":"442","author":"Tanaka","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaci.2021.11.016_bib65","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.190.6.875","article-title":"Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor","volume":"190","author":"Kitamura","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.11.016_bib66","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.jaci.2021.11.016_bib67","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2003-05-1565","article-title":"High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis","volume":"103","author":"Uchida","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.11.016_bib68","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1586\/17476348.2015.1035259","article-title":"Pulmonary alveolar proteinosis: time to shift?","volume":"9","author":"Papiris","year":"2015","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaci.2021.11.016_bib69","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41467-021-21011-y","article-title":"Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis","volume":"12","author":"Sakaue","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2021.11.016_bib70","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1183\/09031936.00197710","article-title":"An open-label trial of rituximab therapy in pulmonary alveolar proteinosis","volume":"38","author":"Kavuru","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2021.11.016_bib71","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMoa1913590","article-title":"Inhaled molgramostim therapy in autoimmune pulmonary alveolar proteinosis","volume":"383","author":"Trapnell","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.016_bib72","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1440-1843.2012.02274.x","article-title":"Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013","volume":"18","author":"Leth","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.jaci.2021.11.016_bib73","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1465-9921-13-46","article-title":"Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis","volume":"13","author":"Malur","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2021.11.016_bib74","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12931-018-0780-5","article-title":"Rituximab for auto-immune alveolar proteinosis, a real life cohort study","volume":"19","author":"Soyez","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2021.11.016_bib75","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fonc.2014.00307","article-title":"Good syndrome, bad problem","volume":"4","author":"Martinez","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaci.2021.11.016_bib76","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5731","article-title":"Aberrant type 1 immunity drives susceptibility to mucosal fungal infections","volume":"371","author":"Break","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.11.016_bib77","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s10875-021-01036-0","article-title":"Neutralizing autoantibodies to type I IFNs in >10% of patients with severe COVID-19 pneumonia hospitalized in Madrid, Spain","volume":"41","author":"Troya","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib78","doi-asserted-by":"crossref","first-page":"e1327","DOI":"10.1002\/cti2.1327","article-title":"Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients","volume":"10","author":"Goncalves","year":"2021","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.jaci.2021.11.016_bib79","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"van der Wijst","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2021.11.016_bib80","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1210\/jc.2008-0935","article-title":"Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I","volume":"93","author":"Meloni","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaci.2021.11.016_bib81","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2021.11.016_bib82","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00134-021-06392-4","article-title":"Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients","volume":"47","author":"Koning","year":"2021","journal-title":"Intensive Care Med"},{"issue":"14","key":"10.1016\/j.jaci.2021.11.016_bib83","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150867","article-title":"Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1","volume":"131","author":"Meisel","year":"2021","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jaci.2021.11.016_bib84","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210554","article-title":"Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1","volume":"218","author":"Bastard","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2021.11.016_bib85","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10875-021-01023-5","article-title":"Interferon-\u03b2 therapy in a patient with incontinentia pigmenti and autoantibodies against type I IFNs infected with SARS-CoV-2","volume":"41","author":"Bastard","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib86","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s10875-021-00994-9","article-title":"Plasma exchange to rescue patients with autoantibodies against type I interferons and life-threatening COVID-19 pneumonia","volume":"41","author":"de Prost","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.016_bib87","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1172\/JCI80477","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"125","author":"Walter","year":"2015","journal-title":"J Clin Invest"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921018005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921018005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:35:55Z","timestamp":1758792955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921018005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0091674921018005"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.11.016","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}